findmyKOL
Clinical trialNCT00000942CompletedPhase 3Interventional

A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Babies

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment1,244HIV InfectionsPregnancy
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France
  • Hopital Hotel Dieu de Lyon

    Lyon, France

  • Chru de Nantes

    Nantes, France

Italy
  • Universita Frederico Ii

    Naples, Italy

Spain
  • Hosp Doce de Octubre

    Madrid, Spain

The Bahamas
  • Princess Margaret Hosp

    Nassau, The Bahamas

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
—
Primary completion
—
Completion
31 May 2001
Last update posted
29 Oct 2021
Registered enrollment
1,244
Registry id
NCT00000942
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.